search

International Journal of Neuropsychopharmacology, Volume 10, Issue Supplement_1, December 2007, Pages S1–S207, https://doi.org/10.1017/S1461145707008255

Published: 01 December 2007

Journal Article

Discontinuation symptoms in depression and anxiety disorders

PDF

David S. Baldwin and others

International Journal of Neuropsychopharmacology, Volume 10, Issue 1, February 2007, Pages 73–84, https://doi.org/10.1017/S1461145705006358

Published: 01 February 2007

Journal Article

Evidence-based pharmacotherapy of generalized anxiety disorder

PDF

David S. Baldwin and Claire Polkinghorn

International Journal of Neuropsychopharmacology, Volume 8, Issue 2, June 2005, Pages 293–302, https://doi.org/10.1017/S1461145704004870

Published: 01 June 2005

Modify your search

Availability

NARROW

Format

Type

Section

Category

Publication date

Placebo Effects Are Small on Average in the 7.5% CO₂ Inhalational Model of Generalized Anxiety

Functional Neuroimaging Correlates of Placebo Response in Patients With Depressive or Anxiety Disorders: A Systematic Review

Brain Functional Connectivity Correlates of Response in the 7.5% CO₂ Inhalational Model of Generalized Anxiety Disorder: A Pilot Study

Evidence-based pharmacological treatment of generalized anxiety disorder

Onset of activity and time to response on individual CAPS-SX₁₇ items in patients treated for post-traumatic stress disorder with venlafaxine ER: a pooled analysis

Antidepressant medications and other treatments of depressive disorders: a CINP Task Force report based on a review of evidence

Discontinuation symptoms in depression and anxiety disorders

Evidence-based pharmacotherapy of generalized anxiety disorder

Email alerts

Modify your search

Publication date

Email alerts

This Feature Is Available To Subscribers Only